Clinical Trial Update: Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

View source ↗

Summary

Pfizer-sponsored clinical trial evaluating epirubicin as part of neo-adjuvant and adjuvant chemotherapy for primary breast cancer has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ELLENCE (Epirubicin hydrochloride)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasm | Status: COMPLETED | Results posted: 2010-11-18